A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment

By Yong P.Y.K.   Brett S.   Baird D.T.   Thong K.J.  

Fertility and Sterility, Vol. 79, Iss. 2, 2003-02 ,pp. : 308-315

Elsevier

Access to resources Recommend Favorite

A Randomized, Double-Blind, Multicenter Study Comparing a Starting Dose of 100 IU or 200 IU of Recombinant Follicle Stimulating Hormone (Puregon®) in Women Undergoing Controlled Ovarian Hyperstimulation for IVF Treatment

By Tan Seang   Child Timothy   Cheung Anthony   Fluker Margo   Yuzpe Albert   Casper Robert   Leung Peter   Cadesky Kenneth   Davis Victoria  

Journal of Assisted Reproduction and Genetics, Vol. 22, Iss. 2, 2005-02 ,pp. : 81-88

Springer Publishing Company

Access to resources Recommend Favorite

A prospective, randomized controlled trial comparing the efficacy of recombinant follicle-stimulating hormone in three different in vitro fertilization protocols

By Ravhon A.   Lawrie H.   Ellenbogen A.   Lavery S.   Trew G.   Winston R.  

Fertility and Sterility, Vol. 73, Iss. 5, 2000-05 ,pp. : 908-912

Elsevier

Access to resources Recommend Favorite

Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment

By Casper F.W.   Seufert R.J.   Schaffrath M.   Pollow K.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 32-37

Elsevier

Access to resources Recommend Favorite

Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization

By Chuang C.-C.   Chen C.-D.   Chao K.-H.   Chen S.-U.   Ho H.-N.   Yang Y.u.-S.  

Fertility and Sterility, Vol. 79, Iss. 1, 2003-01 ,pp. : 63-68

Elsevier

Access to resources Recommend Favorite